Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart…
- A. Hjalmarson, S. Goldstein, +20 authors P. Deedwania
- Medicine
- JAMA
- 8 March 2000
CONTEXT
Results from recent studies on the effects of beta1-blockade in patients with heart failure demonstrated a 34% reduction in total mortality. However, the effect of beta1-blockade on the… Expand
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
- Å. Hjalmarson, S. Goldstein, +348 authors L. Yellen
- Medicine
- 12 June 1999
BACKGROUND: Metoprolol can improve haemodynamics in chronic heart failure, but survival benefit has not been proven. We investigated whether metoprolol controlled release/extended release (CR/XL)… Expand
EFFECTS OF A NOVEL TETRAPEPTIDE IN HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF): A PHASE I RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ELAMIPRETIDE
- M. Daubert, Eric Yow, +6 authors H. N. Sabbah
- Medicine
- 1 April 2016
Elamipretide is a novel tetrapeptide that targets mitochondrial dysfunction and has the potential to augment cardiac function in HFrEF.
To assess the safety of elamipretide, 36 subjects with EF ≤… Expand
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
- W. Rogers, A. Epstein, +381 authors L. Walters
- Medicine
- The New England journal of medicine
- 1992
BACKGROUND
The Cardiac Arrhythmia Suppression Trial (CAST) tested the hypothesis that the suppression of asymptomatic or mildly symptomatic ventricular premature depolarizations in survivors of… Expand
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
- J. Ghali, J. Wikstrand, +9 authors H. Wedel
- Medicine
- Journal of cardiac failure
- 1 May 2009
BACKGROUND
Limited information is available on the risk and impact of renal dysfunction on the response to beta-blockade and mode of death in systolic heart failure (HF).
METHODS AND RESULTS
Renal… Expand
Transplantation of cultured human neuronal cells for patients with stroke
- D. Kondziolka, L. Wechsler, +9 authors L. Bynum
- Medicine
- 22 August 2000
Article abstract Transplantation of cultured neuronal cells is safe in animal models and improves motor and cognitive deficits in rats with stroke. The authors studied the safety and feasibility of… Expand
Continuous insulin infusion is associated with a reduced post-surgical length of stay, but not with the complication rate, in patients with diabetes mellitus undergoing coronary artery bypass graft
- Z. Abelev, A. Seth, +9 authors L. Poretsky
- Medicine
- Journal of endocrinological investigation
- 27 May 2011
Objective: To establish if glucose management with continuous intravenous insulin infusion (CII) in the early post-operative period after coronary artery bypass graft (CABG) surgery is associated… Expand
Achieved metoprolol CR/XL dose and clinical outcome Analysis of the experience in MERIT-HF
- A. Hjalmarson, J. Wikstrand, +4 authors H. Wedel
- Medicine
- 3 August 2001
- 4
PREVENTION / 3-ADRENERGIC BLOCKADE Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
- S. Goldstein, R. Byington, J. Curb
- 2005
The incidence of congestive heart failure was studied in the Beta Blocker Heart Attack Trial in which postmyocardial infarction patients between the ages of 30 and 69 years, with no contraindication… Expand